Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist

24 REAL-WORLD COMPARISON OF TOFACITINIB VERSUS USTEKINUMAB AMONG ULCERATIVE COLITIS PATIENTS WITH PRIOR ANTI-TUMOR NECROSIS FACTOR ALPHA AND ANTI-INTEGRIN TREATMENT FAILURE: A PROPENSITY SCORE-ADJUSTED ANALYSIS

Gastroenterology ◽

10.1016/s0016-5085(21)00761-7 ◽

2021 ◽

Vol 160 (6) ◽

pp. S-5

Author(s):

Rahul S. Dalal ◽

Jennifer Mitri ◽

Hannah Goodrick ◽

Jessica R. Allegretti

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Propensity Score ◽

Treatment Failure ◽

Real World ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis

Journal of the Anus Rectum and Colon ◽

10.23922/jarc.2016-008 ◽

2017 ◽

Vol 1 (4) ◽

pp. 106-111

Author(s):

Motoi Uchino ◽

Hiroki Ikeuchi ◽

Toshihiro Bando ◽

Akihiro Hirata ◽

Teruhiro Chohno ◽

...

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Restorative Proctocolectomy ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Alpha Level ◽

Factor Alpha ◽

Necrosis Factor ◽

Serum Tumor Necrosis

Effect of the Polymorphism of Tumor Necrosis Factor-α-308 G/A Gene Promoter on the Susceptibility to Ulcerative Colitis: A Meta-Analysis

Digestion ◽

10.1159/000158605 ◽

2008 ◽

Vol 78 (1) ◽

pp. 44-51 ◽

Cited By ~ 11

Author(s):

Zonghai Lu ◽

Lei Chen ◽

Hui Li ◽

Yanjun Zhao ◽

Lin Lin

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Meta Analysis ◽

Gene Promoter ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Tumor Necrosis Factor-Alpha Antagonist-Induced Sarcoidosis

JCR Journal of Clinical Rheumatology ◽

10.1097/rhu.0b013e3181efa190 ◽

2010 ◽

Vol 16 (6) ◽

pp. 274-279 ◽

Cited By ~ 38

Author(s):

Rochelle Robicheaux Clementine ◽

Justin Lyman ◽

Jerald Zakem ◽

Jyothi Mallepalli ◽

Stephen Lindsey ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Alpha Antagonist ◽

Paradoxical Response to Tuberculosis Treatment in a Patient Receiving Tumor Necrosis Factor-Alpha Antagonist

The American Journal of Medicine ◽

10.1016/j.amjmed.2012.02.006 ◽

2012 ◽

Vol 125 (6) ◽

pp. e9-e10 ◽

Cited By ~ 4

Author(s):

Caroline Moureau ◽

Lucie Pothen ◽

Dunja Wilmes ◽

Jean Cyr Yombi ◽

Emmanuel Coche ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tuberculosis Treatment ◽

Necrosis Factor Alpha ◽

Paradoxical Response ◽

Factor Alpha ◽

Alpha Antagonist ◽

Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review

BMC Gastroenterology ◽

10.1186/s12876-020-01332-w ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Ulf Helwig ◽

Michael Mross ◽

Stefan Schubert ◽

Heinz Hartmann ◽

Alina Brandes ◽

...

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Chart Review ◽

Retrospective Chart Review ◽

Clinical Effectiveness ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe

Clinical Microbiology and Infection ◽

10.1111/j.1469-0691.2011.03674.x ◽

2012 ◽

Vol 18 (7) ◽

pp. 670-676 ◽

Cited By ~ 35

Author(s):

P. Zanger ◽

I. Kötter ◽

P.G. Kremsner ◽

S. Gabrysch

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Alpha Antagonist ◽

Tumor necrosis factor-alpha antagonist therapy-induced psoriasis in Turkey: analysis of 514 patients

Modern Rheumatology ◽

10.3109/s10165-011-0590-9 ◽

2012 ◽

Vol 22 (5) ◽

pp. 738-742 ◽

Cited By ~ 6

Author(s):

Ediz Dalkilic ◽

Emel Bulbul Baskan ◽

Nihan Alkis ◽

Mustafa Gullulu ◽

Mahmut Yavuz ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Antagonist Therapy ◽

Factor Alpha ◽

Alpha Antagonist ◽

Sa556 HIGHER SERUM ALBUMIN IS ASSOCIATED WITH STEROID-FREE CLINICAL REMISSION AMONG ULCERATIVE COLITIS PATIENTS INITIATING TOFACITINIB THERAPY AFTER ANTI-TUMOR NECROSIS FACTOR ALPHA AND ANTI-INTEGRIN TREATMENT FAILURE

Gastroenterology ◽

10.1016/s0016-5085(21)02012-6 ◽

2021 ◽

Vol 160 (6) ◽

pp. S-549-S-550

Author(s):

Rahul S. Dalal ◽

Emma L. McClure ◽

Jessica R. Allegretti

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Serum Albumin ◽

Treatment Failure ◽

Clinical Remission ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Tumor Necrosis Factor-Alpha Polymorphisms in Ulcerative Colitis-Associated Colorectal Cancer

The American Journal of Gastroenterology ◽

10.1111/j.1572-0241.2007.01572.x ◽

2008 ◽

Vol 103 (2) ◽

pp. 407-415 ◽

Cited By ~ 38

Author(s):

Megan M. Garrity-Park ◽

Edward V. Loftus ◽

Sandra C. Bryant ◽

William J. Sandborn ◽

Thomas C. Smyrk

Keyword(s):

Colorectal Cancer ◽

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽